Get the Stockscreener App
10.49
1.06%
0.11
After Hours:
10.54
0.05
+0.48%
Adma Biologics Inc stock is traded at $10.49, with a volume of 5.72M.
It is up +1.06% in the last 24 hours and down -30.76% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
See More
Previous Close:
$10.38
Open:
$10.36
24h Volume:
5.72M
Relative Volume:
1.14
Market Cap:
$2.50B
Revenue:
$510.17M
Net Income/Loss:
$146.93M
P/E Ratio:
17.51
EPS:
0.599
Net Cash Flow:
$27.51M
1W Performance:
+13.28%
1M Performance:
-30.76%
6M Performance:
-29.83%
1Y Performance:
-49.83%
1-Day Range:
$10.31
$10.76
1-Week Range:
$9.315
$10.76
52-Week Range:
$7.2101
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
10.49 | 2.31B | 510.17M | 146.93M | 27.51M | 0.599 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating - PR Newswire
Technical Reactions to ADMA Trends in Macro Strategies - Stock Traders Daily
ADMA Biologics (ADMA) soars 11.6% as firm denies short seller allegations - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Jumps 7.6% to $10.44 - AlphaStreet
ADMA Biologics Price Target Cut to $24.00/Share From $30.00 by Mizuho - Moomoo
Aug Mood: Can ADMA Biologics Inc outperform in the next rally2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
ADMA Maintains Outperform Rating by Mizuho -- Price Target Lowered to $24 - GuruFocus
Risk Check: Why is ADMA Biologics Inc stock going up2026 Sentiment & Detailed Earnings Play Alerts - baoquankhu1.vn
ADMA Biologics Investigated for Alleged Securities Fraud - National Today
$ADMA Investigation Reminder: ADMA Biologics Investors are - GlobeNewswire
ADMA Biologics gains after refuting short seller claims - MSN
Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral, Here’s Why - Yahoo Finance
EV Market: Why is ADMA Biologics Inc stock going upBull Run & Momentum Based Trading Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Gap Down: Is ADMA Biologics Inc subject to activist investor interestStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - The Globe and Mail
Is ADMA Poised for Margin Growth and Supply Expansion in 2026? - TradingView — Track All Markets
A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations - Sahm
ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims - National Today
ADMA Biologics Faces Securities Fraud Investigation Over Alleged Channel Stuffing - National Today
ADMA News Today | Why did ADMA Biologics stock go up today? - MarketBeat
Growth Value: Whats the fair value of ADMA Biologics Inc stock2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Growth Value: Is ADMA Biologics Inc attractive for institutional investors2026 Price Swings & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Adma Biologics (ADMA) Laps the Stock Market: Here's Why - Yahoo Finance
ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire
Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire
ADMA Technical Analysis & Stock Price Forecast - Intellectia AI
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail
Lowey Dannenberg, P.C. is Investigating ADMA Biologics - GlobeNewswire
ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
ADMA Biologics Under Investigation for Securities Violations - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha
Aberdeen Group Reduces ADMA Biologics Stake - National Today
ADMA Biologics Inc $ADMA Stock Holdings Lessened by Aberdeen Group plc - MarketBeat
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
Will Securities Probes Into Alleged Channel Stuffing Change ADMA Biologics' (ADMA) Narrative? - Sahm
ADMA stock downgraded by Cantor as ‘channel stuffing’ claims shake investor confidence - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% - GlobeNewswire
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics slams short seller claims, highlights strong demand - MSN
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):